Current Diabetes Reports

, Volume 6, Issue 3, pp 241–250 | Cite as

Type 2 diabetes and the metabolic syndrome in children and adolescents

Article

Abstract

The prevalence rates of obesity, metabolic syndrome, and type 2 diabetes in children are increasing at an alarming rate. The potential impact of these conditions on the individual, the family, and society, especially in regard to the costs and utilization of health care resources, are very serious. Strategies aimed at reducing caloric intake, increasing caloric expenditure through regular exercise, and treating cardiovascular risk factors and type 2 diabetes early and aggressively are necessary to meet the challenges they impose.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Type 2 diabetes in children and adolescents. American Diabetes Association [no authors listed]. Pediatrics 2000,105:671-680.Google Scholar
  2. 2.
    Bobo N, Evert A, Gallivan J, et al.: An update on type 2 diabetes in youth from the National Diabetes Education Program. Pediatrics 2004, 114:259–263.PubMedCrossRefGoogle Scholar
  3. 3.
    GungorN, Hannon T, Libman I, et al.: Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am 2005, 52:1579–1609. This is an excellent review of type 2 DM by a group of investigators who are very active in this area of research. The report describes the current epidemiology, pathophysiology, and treatment of type 2 DM in children and highlights some of the newer studies on these topics.PubMedCrossRefGoogle Scholar
  4. 4.
    Banerji MA, Chaiken RL, Huey H, et al.: GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994, 43:741–745.PubMedCrossRefGoogle Scholar
  5. 5.
    Chaiken RL, Banerji MA, Pasmantier R, et al.: Patterns of glucose and lipid abnormalities in black NIDDM subjects. Diabetes Care 1991, 14:1036–1042.PubMedCrossRefGoogle Scholar
  6. 6.
    AlbertiG, Zimmet P, Shaw J, et al.: Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation (IDF) consensus workshop. Diabetes Care 2004, 27:1798–1811. This publication represents the output of the workshop on type 2 DM in children sponsored by the International Diabetes Federation. It is a very good review, but has the added value of providing a more "global" picture of type 2 DM to the reader.PubMedCrossRefGoogle Scholar
  7. 7.
    Weiss R, Caprio S, Trombetta M, et al.: Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005, 54:1735–1743.PubMedCrossRefGoogle Scholar
  8. 8.
    GungorN, Bacha F, Saad R, et al.: Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005, 28:638–644. This report from the Pittsburg group provides information regarding the pathophysiology of type 2 DM, especially in regard to the role of pancreatic β-cell dysfunction.PubMedCrossRefGoogle Scholar
  9. 9.
    Amiel SA, Sherwin RS, Simonson DC, et al.: Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1968, 314:215–219.Google Scholar
  10. 10.
    Amiel SA, Caprio S, Sherwin RS, et al.: Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991, 73:277–282.CrossRefGoogle Scholar
  11. 11.
    Moran A, Jacobs DR Jr, Steinberger J, et al.: Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999, 48:2039–2044.PubMedCrossRefGoogle Scholar
  12. 12.
    SinhaR, Fisch G, Teague B, et al.: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346:802–810. Sinha et al.’s report describes the results of testing for impaired glucose tolerance and type 2 DM in a fairly random group of overweight children. Their findings indicate that a significant number of overweight children have impaired glucose tolerance and/or type 2 DM, a disturbing observation given the rising prevalence of overweight in children.PubMedCrossRefGoogle Scholar
  13. 13.
    Klein DJ, Aronson Friedman L, Harlan WR, et al.: Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study. Diabetes Care 2004, 27:378–383.PubMedCrossRefGoogle Scholar
  14. 14.
    Saad RJ, Danadian K, Lewy V, Arslanian SA: Insulin resistance of puberty in African-American children: lack of a compensatory increase in insulin secretion. Pediatr Diabetes 2002, 3:1–3.CrossRefGoogle Scholar
  15. 15.
    Miller J, Rosenbloom A, Silverstein J: Childhood obesity. J Clin Endocrinol Metab 2004, 89:4211–4218.PubMedCrossRefGoogle Scholar
  16. 16.
    DietzWH, Robinson TN: Overweight children and adolescents. N Engl J Med 2005, 352:2100–2109. This is an excellent review of the problem of overweight in children. It provides significant insight into the issues that surround excessive weight gain in children.PubMedCrossRefGoogle Scholar
  17. 17.
    Department of Health and Human Services, Centers for Disease Control and Prevention: Overweight and obesity: defining overweight and obesity. http://www.cdc.gov/nccdphp/dnpa/bmi/bmi-for-age.htm.Google Scholar
  18. 18.
    Daniels SR, Arnett DK, Exkel RH, et al.: Overweight in children and adolescents, pathophysiology, consequences, prevention, and treatment. Circulation 2005, 111:1999–2012.PubMedCrossRefGoogle Scholar
  19. 19.
    Levitsky LL: Type 2 diabetes: the new epidemic of childhood. Paper presented at the Annual Meeting of the American Academy of Pediatrics. Boston, MA; October 18-23, 2002.Google Scholar
  20. 20.
    Kant AK: Reported consumption of low-nutrient-density foods by American children and adolescents: nutritional and health correlates, NHANES III, 1988 to 1994. Arch Pediatr Adolesc Med 2003, 157:789–796.PubMedCrossRefGoogle Scholar
  21. 21.
    American Academy of Pediatrics Committee on School Health: Soft drinks in schools. Pediatrics 2004, 113:152–154.CrossRefGoogle Scholar
  22. 22.
    Bowman SA, Gortmaker SL, Ebbeling CB, et al.: Effects of fast-food consumption on energy intake and diet quality among children in a national household survey. Pediatrics 2004, 113(1 Pt 1):112–118.PubMedCrossRefGoogle Scholar
  23. 23.
    Vincent SD, Pangrazi RP, Raustorp A, et al.: Activity levels and body mass index of children in the United States, Sweden, and Australia. Med Sci Sports Exerc 2003, 35:1367–1373.PubMedCrossRefGoogle Scholar
  24. 24.
    Levin S, Lowry R, Brown DR, Dietz WH: Physical activity and body mass index among US adolescents: youth risk behavior survey, 1999. Arch Pediatr Adolesc Med 2003, 157:816–820.PubMedCrossRefGoogle Scholar
  25. 25.
    American Academy of Pediatrics Committee on Public Education: American Academy of Pediatrics: Children, adolescents, and television. Pediatrics 2001, 107:423–426.CrossRefGoogle Scholar
  26. 26.
    Fallon EM, Tanofsky-Kraff M, Norman AC, et al.: Healthrelated quality of life in overweight and nonoverweight black and white adolescents. J Pediatr 2005, 147:443–450.PubMedCrossRefGoogle Scholar
  27. 27.
    Park MK, Menard SW, Schoolfield J: Prevalence of overweight in a triethnic pediatric population of San Antonio, Texas. Int J Obes Relat Metab Disord 2001, 25:409–416.PubMedCrossRefGoogle Scholar
  28. 28.
    Davis SP, Northington L, Kolar K: Cultural considerations for treatment of childhood obesity. J Cult Divers 2000, 7:128–132.PubMedGoogle Scholar
  29. 29.
    Smith SC Jr, Clark LT, Cooper RS, et al.: Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation 2005, 111:e134-e139.PubMedCrossRefGoogle Scholar
  30. 30.
    GrundySM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: executive summary. Circulation 2005, 112:e285-e290. This report should be required reading for all pediatric primary care and specialty health care providers. Through its discussion of the metabolic syndrome and its significance as a risk factor for type 2 DM and CV disease, it brings into sharp focus the importance of proper prevention and treatment of excessive childhood weight gain.CrossRefGoogle Scholar
  31. 31.
    Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289–2304.PubMedCrossRefGoogle Scholar
  32. 32.
    The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdfGoogle Scholar
  33. 33.
    WeissR, Dziura J, Burgert T, et al.: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004, 350:2362–2374. This manuscript is a must for anyone interested in the topic of metabolic syndrome in children. It is a well-written review that addresses important aspects of obesity and the metabolic syndrome as they relate to the pediatric population.PubMedCrossRefGoogle Scholar
  34. 34.
    Zhu W, Huang X, He J, et al.: Arterial intima-media thickening and endothelial dysfunction in obese Chinese children. Eur J Pediatr 2005, 164:337–344.PubMedCrossRefGoogle Scholar
  35. 35.
    Hillier TA, Pedula KL: Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003, 26:2999–3005.PubMedCrossRefGoogle Scholar
  36. 36.
    Gungor N, Thompson T, Sutton-Tyrrell K, et al.: Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care 2005, 28:1219–1221.PubMedCrossRefGoogle Scholar
  37. 37.
    Barker DJP, Osmond C, Forsen TJ, et al.: Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005, 353:1802–1809.PubMedCrossRefGoogle Scholar
  38. 38.
    McMillenIC, Robinson JF: Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005, 85:571–633. McMillen and Robinson’s review of the fetal origins of adult obesity, metabolic syndrome, type 2 DM, and CV disease is an exhaustive compilation of the human and animal research performed on this topic. Although it may be more useful for the researcher than the clinician, the reference list alone with 570 citations has significant value.PubMedCrossRefGoogle Scholar
  39. 39.
    Singhal A, Fewtrell M, Cole TJ, Lucas A: Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet 2003, 361:1089–1097.PubMedCrossRefGoogle Scholar
  40. 40.
    Rolland-Cachera MF, Deheeger M, Bellisle F, et al.: Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 1984, 39:129–135.PubMedGoogle Scholar
  41. 41.
    KnowlerWC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403. This manuscript describes the results of one of the first large-scale diabetes prevention studies. Subjects at risk for type 2 DM were randomized to routine weight counseling (controls), lifestyle intervention focusing on modifications in dietary intake and physical activity, or metformin therapy. After an average followup of 2.8 years, lifestyle intervention reduced the incidence of diabetes by 58% and metformin by 31%, compared with controls. The importance of lifestyle intervention is evident.PubMedCrossRefGoogle Scholar
  42. 42.
    Knowler WC, Hamman RF, Edelstein SL, et al.: Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes 2005, 54:1150–1156.PubMedCrossRefGoogle Scholar
  43. 43.
    Scheen AJ, Ernest P: New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. Diabetes Metab 2002, 28(6 Pt 1):437–445.PubMedGoogle Scholar
  44. 44.
    Volek JS, Feinman RD: Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005, 2:31.CrossRefGoogle Scholar
  45. 45.
    Utzschneider KM, Carr DB, Barsness SM, et al.: Dietinduced weight loss is associated with an improvement in beta-cell function in older men. J Clin Endocrinol Metab 2004, 89:2704–2710.PubMedCrossRefGoogle Scholar
  46. 46.
    Gottschalk M, Danne T, Cara J, et al.: Glimepiride (GLIM) vs metformin (MET) as monotherapy in pediatric patients with T2DM: a single-blind comparison study. Abstract presented at the 31st Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD). Krakow, Poland; August 31 to September 3, 2005.Google Scholar
  47. 47.
    Stratton IM, Kohner EM, Aldington SJ, et al.: UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44:156–163.PubMedCrossRefGoogle Scholar
  48. 48.
    Nathan DM, Cleary PA, Backlund JY, et al.: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005, 353:2643–2653.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc. 2006

Authors and Affiliations

  1. 1.Pflzer Global PharmaceuticalsPflzer, Inc.New YorkUSA

Personalised recommendations